As disclosures of life science industry payments to healthcare professionals continue with rollouts such as the Centers for Medicare and Medicaid Services’ Open Payments Database in late September, Thought Leader Select’s Paul Meade has been a sought-after expert on the impact of these disclosures on industry collaborations with key opinion leaders in medicine. Meade, the …
Industry Insights from Kristen Smithwick Last week proved to be another interesting week for the developing Sunshine Act. Senators Chuck Grassley (R-IA) and Herb Kohl (D-WI) sent a pivotal memo to Acting CMS Administrator Marilyn Tavenner. The senators urged the agency to publish a final rule no later than June 2012 and to respond to …
Industry Insights from Kristen Smithwick Albeit a bit late, the U. S. Centers for Medicare and Medicaid Services (CMS) issued a proposed rule on the Patient Protection & Affordable Care Act’s Physician Payments Sunshine Provision (also known as the “Sunshine Act”) to implement it as law. CMS invited comments on the proposed rule through mid-February …
Industry Insights from Paul Meade, M. Sc, MPH For every transaction over ten dollars paid to a physician by a pharmaceutical manufacturer, the Physician Payments Sunshine Provision demands disclosure to a database that will be made public in 2013. Notwithstanding the absurdity of collecting such an enormous amount of information, someone will undoubtedly spend a …
Industry Insights from Paul Meade, M. Sc, MPH The Sunshine Act is on the horizon, and all we know for certain is that things will be different. Will the changes be good, bad, or ugly for healthcare and the biopharmaceutical industry? Well, a bit of all three. But it is a bit like the Y2K …
The Sunshine Act: The Good, the Bad, and the Ugly Read More »
Industry Insights from Paul Meade, M.Sc., MPH By now, just about everyone involved in healthcare has heard about the Sunshine Provision (also known as the Sunshine Act). Starting January 1, 2012, any U.S. drug or device manufacturer that provides compensation to a physician or medical institution for any kind of services rendered will have to …
Industry Insights from Paul Meade, M.Sc., MPH The Physician Payment Sunshine Provision is a part of the Patient Protection and Affordable Care Act passed by the U. S. Congress in March of last year. The provision will go into effect on January 1, 2012. Many people in the healthcare industry are struggling to determine if …
Transparency and the Sunshine Provision – Is This a Good or Bad Thing? Read More »
Industry Insights from Paul Meade, M.Sc. MPH With the Sunshine Act getting closer to implementation, every company that works with thought leaders is preparing for full disclosure and transparency in the way they work and compensate these physicians and other medical experts. So the big question at hand is this–just how many thought leaders should …
The Sunshine Act and Working with Thought Leaders Read More »
To assist healthcare professionals dealing with challenges surrounding the Sunshine Act, Physicians Practice magazine turned to Thought Leader Select Vice President, Kristen Smithwick, for counsel. Smithwick compiled step-by-step recommendations on navigating the new regulations to enable the continued collaboration between physicians and industry:
With the future of medical innovation hanging in the balance, confusion surrounding the Sunshine Act has left those in the pharmaceutical industry in need of insight as they decide how best to collaborate with physicians. To address these concerns, the Pharmaceutical Compliance Monitor (PCM), a publication spotlighting regulatory and compliance news and developments for the …
Pharma Compliance Monitor Solicits Industry Advice from Meade Read More »
